1. Serum miR-181a and miR-25 in patients with malignant and benign breast diseases
   M.L. Perepechaeva et al, 2023, Biomeditsinskaya Khimiya CrossRef
2. Deciphering the Enigmatic Influence: Non-Coding RNAs Orchestrating Wnt/β-Catenin Signaling Pathway in Tumor Progression
   Xinbing Yang et al, 2023, International Journal of Molecular Sciences CrossRef
3. SERUM MIR-181А AND MIR-25 LEVELS IN PATIENTS WITH BREAST CANCEROR A BENIGN BREAST DISEASE
   A. I. Autenshlyus et al, 2023, Доклады Российской академии наук. Науки о жизни CrossRef
4. New insights of LncRNAs fingerprints in breast cancer progression: Tumorigenesis, drug resistance, and therapeutic opportunities
   Bashdar Mahmud Hussen et al, 2025, International Journal of Biological Macromolecules CrossRef
5. Organoids as a model system for researching human neuroendocrine tumor of the breast
   Dongyi Zhao et al, 2024, Cancer Cell International CrossRef
6. Serum miR-181а and miR-25 Levels in Patients with Breast Cancer or Benign Breast Disease
   A. I. Autenshlyus et al, 2023, Doklady Biochemistry and Biophysics CrossRef